These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26682791)

  • 1. Pathogenic Gut Flora in Patients With Chronic Heart Failure.
    Pasini E; Aquilani R; Testa C; Baiardi P; Angioletti S; Boschi F; Verri M; Dioguardi F
    JACC Heart Fail; 2016 Mar; 4(3):220-7. PubMed ID: 26682791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered intestinal function in patients with chronic heart failure.
    Sandek A; Bauditz J; Swidsinski A; Buhner S; Weber-Eibel J; von Haehling S; Schroedl W; Karhausen T; Doehner W; Rauchhaus M; Poole-Wilson P; Volk HD; Lochs H; Anker SD
    J Am Coll Cardiol; 2007 Oct; 50(16):1561-9. PubMed ID: 17936155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired resolution of inflammation in human chronic heart failure.
    Reina-Couto M; Carvalho J; Valente MJ; Vale L; Afonso J; Carvalho F; Bettencourt P; Sousa T; Albino-Teixeira A
    Eur J Clin Invest; 2014 Jun; 44(6):527-38. PubMed ID: 24673112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on bacterial endotoxin and intestinal absorption function in patients with chronic heart failure.
    Sandek A; Bjarnason I; Volk HD; Crane R; Meddings JB; Niebauer J; Kalra PR; Buhner S; Herrmann R; Springer J; Doehner W; von Haehling S; Anker SD; Rauchhaus M
    Int J Cardiol; 2012 May; 157(1):80-5. PubMed ID: 21190739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are pathogenic intestinal bacteria present in stool specimens from patients with chronic heart failure?
    Huntley D; Mollar A; Buesa J; Rodríguez S; Giménez E; Sanchis J; Núñez J; Navarro D
    Diagn Microbiol Infect Dis; 2018 Jun; 91(2):141-143. PubMed ID: 29433998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of carbohydrate antigen 125 in chronic heart failure may be caused by mechanical extension of mesothelial cells from serous cavity effusion.
    Huang F; Zhang K; Chen J; Cai Q; Liu X; Wang T; Lv Z; Wang J; Huang H
    Clin Biochem; 2013 Nov; 46(16-17):1694-700. PubMed ID: 24060730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure.
    Jankowska EA; Ponikowska B; Majda J; Zymlinski R; Trzaska M; Reczuch K; Borodulin-Nadzieja L; Banasiak W; Ponikowski P
    Int J Cardiol; 2007 Feb; 115(2):151-5. PubMed ID: 16782216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure.
    Zhang Z; Cai B; Sun Y; Deng H; Wang H; Qiao Z
    Front Cardiovasc Med; 2022; 9():1076806. PubMed ID: 36704458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.
    Jankowska EA; Pietruk-Kowalczyk J; Zymliński R; Witkowski T; Ponikowska B; Sebzda T; Rzeczuch K; Borodulin-Nadzieja L; Hańczycowa H; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Aug; 59(8):115-27; commentary 126-7. PubMed ID: 14560326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C-reactive protein is elevated in heart failure patients with central sleep apnea and Cheyne-Stokes respiration.
    Schmalgemeier H; Bitter T; Fischbach T; Horstkotte D; Oldenburg O
    Respiration; 2014; 87(2):113-20. PubMed ID: 23988380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for structural alterations in resistance arteries of patients with severe congestive heart failure.
    Mengden T; Douven C; Vetter H; Düsing R
    J Vasc Res; 1999; 36(3):229-34. PubMed ID: 10393509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated plasma amylase levels in advanced chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy: correlation with circulating interleukin-6 activity.
    Parissis JT; Adamopoulos SN; Venetsanou KF; Karas SM; Kremastinos DT
    J Interferon Cytokine Res; 2003 Jun; 23(6):329-33. PubMed ID: 12859859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Features of intestine microbiocenosis and systemic inflammation factors in chronic heart failure patients].
    Egorova EN; Sergeeva SI; Mazur VV; Kalinkin MN; Mazur ES
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (5):72-6. PubMed ID: 22145354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation and endothelial dysfunction in dogs with congestive heart failure.
    Cunningham SM; Rush JE; Freeman LM
    J Vet Intern Med; 2012; 26(3):547-57. PubMed ID: 22489997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
    Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD
    Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
    Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
    Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating forms of human atrial natriuretic peptide in patients with congestive heart failure.
    Ando K; Hirata Y; Emori T; Shichiri M; Kurosawa T; Sato K; Marumo F
    J Clin Endocrinol Metab; 1990 Jun; 70(6):1603-7. PubMed ID: 2140832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nitrotyrosine plasma levels in relation to systemic markers of inflammation and myeloperoxidase in chronic heart failure.
    Eleuteri E; Di Stefano A; Ricciardolo FL; Magno F; Gnemmi I; Colombo M; Anzalone R; Cappello F; La Rocca G; Tarro Genta F; Zummo G; Giannuzzi P
    Int J Cardiol; 2009 Jul; 135(3):386-90. PubMed ID: 19046613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High classification of chronic heart failure increases risk of overactive bladder syndrome and lower urinary tract symptoms.
    Chiu AF; Liao CH; Wang CC; Wang JH; Tsai CH; Kuo HC
    Urology; 2012 Feb; 79(2):260-5. PubMed ID: 22137542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.